| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 601.88 | 93 |
| GSM780708 | Untreated after 4 days (C2_1) | 441.345 | 91 |
| GSM780709 | Untreated after 4 days (C3_1) | 448.936 | 91 |
| GSM780719 | Untreated after 4 days (C1_2) | 606.669 | 93 |
| GSM780720 | Untreated after 4 days (C2_2) | 517.322 | 92 |
| GSM780721 | Untreated after 4 days (C3_2) | 516.022 | 92 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 361.516 | 89 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 536.283 | 92 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 499.67 | 92 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 388.095 | 90 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 596.124 | 93 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 549.665 | 92 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 551.032 | 92 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 461.895 | 91 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 573.199 | 92 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 669.011 | 93 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 510.139 | 92 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 566.428 | 92 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 732.859 | 94 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 553.081 | 92 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 591.243 | 93 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 689.016 | 94 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 481.985 | 91 |